If you are wondering whether Madrigal Pharmaceuticals’ current share price reflects its true worth, this article will walk through what the numbers are saying about value.
The stock last closed at US$482.45, with a 7 day return of a 3.6% decline, a 30 day return of an 18.8% decline and a year to date return of an 18.8% decline, while the 1 year return sits at 49.4%, the 3 year return at 75.4% and the 5 year return at 285.3%.
Recent attention on Madrigal Pharmaceuticals has centered on company specific developments and sector sentiment that have kept the stock in focus for many investors. Together, these news items help explain why the share price has moved around in the short term while still showing strong longer term returns.
